Results for '5 e''
Browse oncology articles matching 5 e' — expert analysis, clinical perspectives, and industry updates from across drug development and care delivery. Use the tabs above for podcasts, press releases, partners, and people for the same search.
Tom Caravela
Mastering the First Impression
first impression, job interviews, professional communication, resume tips, LinkedIn profile
Why is a first impression so important? Mainly because it could also be your last, and only, impression on someone. Oftentimes, job seekers can fail at conveying a positive first impression, and they will unfortunately never get another chance to show who they truly are. This is an area that I feel …
Jan 29th • 2 mins read
Tom Caravela
Interview Differentiator-Be a Story Teller
interview preparation, effective interviewing, behavioral interview questions, storytelling in interviews, successful interview techniques
When you search Google for the words “Interview Preparation,” you will come up with approximately 756,000,000 results. While I am sure you can find an abundance of valuable information, it is very difficult to navigate through all of the content available on the Internet to determine wha…
Mar 22nd • 1 min read
Tom Caravela
“Extreme Interviewing” – MSL Interview Tips and Insights from Medical Affairs Leaders
Extreme Interviewing, Medical Science Liaison, Emotional Intelligence, Hiring Process, Interview Tips
What is “Extreme Interviewing”? Is there such a thing? Does this term even exist in the dictionary? The short, and maybe obvious, answer is “No.” So perhaps I am guilty of coining a new term for the purpose of this article, but it is a concept that is very relevant and worth…
Jul 9th • 1 min read
Tom Caravela
Job Search Checklist for Aspiring Medical Science Liaisons
Medical Science Liaison, MSL role, MSL career tips, Pharmaceutical industry jobs, Break into MSL career
Tips to Help Break into Your First MSL Role The Medical Science Liaison (MSL) role, has become one of the most sought-after career paths in the Pharmaceutical and Biotech industry. What does it take to land a role as a Medical Science Liaison? As an MSL Recruiter, this is a question that I am…
May 17th • 2 mins read
Tom Caravela
MSL Retention – What Matters Most
digital marketing, search engine optimization, keyword analysis, content strategy, online visibility
As the Medical Science Liaison job market continues to become more and more competitive, attrition rates continue to increase as a result. One of the most common questions I receive from MSL Directors and Medical Affairs leaders is, “What can we do to keep our MSLs loyal and motivated?” …
Mar 15th • 2 mins read
Tom Caravela
MSL Hiring and Recruitment: 5 Ways to Support Diversity and Inclusion
Medical Science Liaison hiring, diversity and inclusion recruitment, diverse interview panel, employee referral program, diversity sourcing strategies
While the COVID-19 pandemic wreaked havoc on many industries, Medical Science Liaison hiring was steady throughout 2020 and continues to remain strong in 2021. The one change in hiring that has become evident is the increase in recruitment practices that support diversity and inclusion. While we may…
May 19th • 2 mins read
Tom Caravela
10 Ways to Make an Impact on a Phone Interview
phone interview tips, importance of phone screen, phone interview preparation, how to express interest in job, phone interview strategies
The phone interview, sometimes referred to by Hiring Managers and Talent Acquisition teams as the “phone screen,” is most often the first step in the interview process. While most job seekers are familiar with this concept and first step, some think of it simply as a formality or a way t…
Apr 9th • 1 min read
Bridget Rasmusson
6 Tips to Ace Your Next MSL Interview!
digital marketing, content optimization, search engine ranking, keyword research, on-page SEO
As a Medical Affairs-focused recruitment firm, we see MSL interview "wins" and slip-ups on a daily basis. From our experience working with candidates across all therapeutic areas and across the entire United States, I've noticed a few trends that might help you get that next interview "win" under yo…
Sep 28th • 1 min read
Tom Caravela
Combatting the “Summer Slow Down" – MSL Job Search Tips for Slower Months
Medical Science Liaison, Medical Affairs recruitment, job search strategies, networking in medical field, summer hiring trends
There is definitely a cyclical nature to hiring Medical Science Liaisons and Medical Affairs professionals. Typically, peak season for recruitment and hiring is from March to June, which is the time-frame in and around which MSLs collect their annual bonuses. However, Medical Science Liaison hiring …
Jun 23rd • 2 mins read
Tom Caravela
What to do When a Job Offer is Rescinded
job offer, rescinded job offer, job search, negotiation, budget cuts, hiring freeze, career advice, networking, job market, job application, job opportunities
First off, there are a couple of reasons why a company might rescind a job offer. Number one, if the person gets an offer and over negotiates or handles the negotiation improperly, it may rub people the wrong way and could lead to the company rescinding the offer. More commonly, the reason why job o…
Jul 20th • 5 mins read
iNIZIO
Clinical Educator Oncology Program Improves Adherence by 29%
CASE STUDY (US) The Challenge Client’s specialty product had a complicated oral therapy regimen requiring supplemental support to patients. Therapy administered for chronic life-threatening condition in which patients are generally older and polypharmic. Our Soluti…
Sep 3rd • 1 min read
iNIZIO
Transforming oncology: Five frontiers driving progress in cancer care
From biomarker-driven breakthroughs to AI-powered early detection and a renewed commitment to equity and patient centricity, the past 12 months have seen major strides across cancer research, treatment, and communication. At Inizio, we’ve had a front-row seat to this transformation, supporting…
May 16th • 5 mins read
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Innovation, Expanded access, Early drug access, Cancer, FDA, EMA
Cancer incidence is increasing globally, and while medical innovation significantly impacts patient survival, the drug development process is lengthy, often exceeding 10 years for marketing authorization (MA). France has implemented the ATU (Temporary Authorization for Use) program to facil…
Apr 7th • 12 mins read
Siddharth Agrawal, Nidhi Bansal
Advances and Challenges in Pediatric and Childhood Cancers
CNS, central nervous system, ES, Ewing sarcoma, MB, medulloblastoma, PTSD, post traumatic stress disorder, RB, retinoblastoma
Pediatric cancers, while uncommon compared to adult cancers, include leukemia, CNS tumors, lymphoma, Wilms' tumor, and retinoblastoma. Challenges in pediatric cancer treatment encompass late diagnosis, varied immune responses, preserving fertility, minimizing late effects, and considering lo…
Jun 27th • 2 mins read
Nicole Grossmann, Martin Robausch, Eleen Rothschedl, Claudia Wild, Judit Simon
Publicly accessible evidence of health-related quality of life benefits associated with cancer drugs approved by the European Medicines Agency between 2009 and 2015
Antineoplastic agents, Health-related quality of life, Clinical efficacy, Drug approvals, Patient-relevant outcomes
The study investigates cancer drugs approved by the European Medicines Agency (EMA) that initially lack Health-related Quality of Life (HRQoL) information. Data was collected for cancer indications approved between January 2009 and October 2015, using sources like the EMA website, clinical…
Feb 23rd • 12 mins read
Carrie Printz
First person profile: Supriya G. Mohile, MD, MS: A respected geriatric oncologist, Dr. Mohile has conducted innovative research on improving care for older patients with cancer
Supriya G. Mohile, geriatric oncologist
Ms. Canin and Dr. Mohile collaborated to involve patients and caregivers in geriatric oncology studies, forming the SCOREboard advisory group. Dr. Mohile received a $2 million grant to create infrastructure for cancer and aging studies, and she is recognized as a leader in geria…
Oct 11th • 2 mins read
Leslie Bernstein, PhD
First person profile: Leslie Bernstein, PhD: An epidemiologist known for her groundbreaking discoveries about breast cancer, Dr. Bernstein continues to push the field forward
breast cancer, Leslie Bernstein, epidemiologist
Dr. Leslie Bernstein is a renowned researcher in breast cancer risk and prevention at City of Hope, California. Her colleague, Dr. Jonine Bernstein, highlights her groundbreaking work and passion for research. They have collaborated on the WECARE Study, focusing on genetic susceptibility and…
Aug 12th • 4 mins read
Envision Pharma Group
Medical affairs: The power behind redefining commercialization
Medical affairs commercialization, integrating science in pharma, redefining medical affairs roles, strategic medical affairs leadership, early engagement with payers, pharmaceutical commercialization strategies, upskilling in medical affairs, medical aff
In March 2024, Envision Pharma Group held a Medical Affairs Professional Society (MAPS) Americas roundtable with leaders discussing the role of science in commercialization strategies and the importance of integrating robust scientific understanding into the commercial journey. Envision revisite…
Aug 2nd • 3 mins read
Paul G. Kluetz, Patricia Keegan, George D. Demetri, Katherine Thornton, Joohee Sul, Janice Kim, Harvey Katzen, Laurie Beth Burke, R. Donald Harvey, Elleni Alebachew, Sundeep Agrawal, Abhilasha Nair, Martha Donoghue
FDA Oncology Center of Excellence Project Renewal: Engaging the Oncology Community to Update Product Labeling for Older Oncology Drugs
FDA labeling format, PLR format, oncology drugs, FDA
The FDA conducts independent reviews of scientific data to ensure the safety and efficacy of investigational drug products. FDA-approved product labeling is a highly trusted source of information for approved drug use. FDA approval is only the beginning of a drug's lifecycle, with ongoing c…
Feb 15th • 13 mins read
Yassine Kamal Lyauk, Daniël Martijn Jonker, Trine Meldgaard Lund
Dose Finding in the Clinical Development of 60 US Food and Drug Administration-Approved Drugs Compared With Learning vs. Confirming Recommendations
FDA, sequential clinical development, drug approvals, clinical trials, dosages
This review evaluates the current practice of dose finding in the pharmaceutical industry and assesses the clinical evidence supporting the optimality of the label dose. Previous work has focused on dose-ranging trial design, while clinical development paths and dose–exposure–res…
Jun 29th • 15 mins read